Month: March 2023

89bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Written by Customer Service on March 10, 2023. Posted in Earnings Releases And Operating Results.

– Topline results from ENLIVEN Phase 2b NASH trial on track for first quarter of 2023 – – Feedback from FDA supports advancement of Phase 3 program for pegozafermin in SHTG; plan to initiate first of two SHTG Phase 3 trials in the second quarter of 2023 – – Published results of Phase 1b/2a study of pegozafermin for the treatment of NASH in The Lancet Gastroenterology & Hepatology – SAN FRANCISCO, March 10, 2023 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today reported its financial results for the fourth quarter and full year ended December 31, 2022. “In 2022, we made significant advancements across our late-stage clinical development program for...

Longeveron Inc. Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Written by Customer Service on March 10, 2023. Posted in Earnings Releases And Operating Results.

— Full results from ELPIS I trial published in European Heart Journal Open – — First patient to be randomized in Japan Aging-Related Phase 2 study in Q1 – — Conference call scheduled for 8:30 a.m. ET today — MIAMI, March 10, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today provided a business update and reported its financial results for the fourth quarter and full year of 2022. “Longeveron had a productive 2022, executing on multiple key milestones as we continued to advance Lomecel-BTM for multiple indications,” said Wa’el Hashad, Chief Executive Officer. “Earlier this year, the full data from our ELPIS I trial of Lomecel-BTM for infants...

ResGreen Publishes Annual Report for 2022 and 2021

Written by Customer Service on March 10, 2023. Posted in Public Companies.

SHELBY TOWNSHIP, Mich., March 10, 2023 (GLOBE NEWSWIRE) — ResGreen Group International, Inc. (RGGI), a next-gen mobile robot and software solutions company, published its annual report for the 2022 and 2021 fiscal years. The report contains financial statements, shareholder information and an auditor’s report. The successfully audited financial statements of ResGreen were completed by BF Borgers CPA, PC, a public accounting firm, registered with the Public Company Accounting Oversight Board (PCAOB). “ResGreen is committed to providing the highest value and transparency to our investors and customers, whether it’s through conducting comprehensive audits, developing leading-edge products and implementing an effective go-to-market strategy,” said Parsh Patel, ResGreen’s CEO. “Our recent sales and marketing efforts have led to several...

DIRTT Announces Transfer to the Nasdaq Capital Market

Written by Customer Service on March 10, 2023. Posted in Public Companies.

CALGARY, Alberta, March 10, 2023 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”) (TSX:DRT, NASDAQ:DRTT), a global leader in industrialized construction, today announced that it has been notified by the Nasdaq Stock Market (“Nasdaq”) that the Company is eligible for an additional 180 calendar day period, or until September 5, 2023, to regain compliance with the Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Rule”). If at any time during this time period the closing bid price of the Company’s common shares is at least $1.00 per share for a minimum of 10 consecutive business days, Nasdaq will provide written confirmation of compliance and the matter will be closed. In connection with the foregoing, the Company’s common shares were transferred...

Bilibili Inc. Announces Inclusion of Its Class Z Ordinary Shares in the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect Programs

Written by Customer Service on March 10, 2023. Posted in Public Companies.

SHANGHAI, China, March 10, 2023 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that the Company’s Class Z ordinary shares traded on The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”) have been included in the Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect programs, both effective March 13, 2023. Following its inclusion, eligible investors in the Chinese Mainland will have direct access to the trading of Bilibili’s Class Z ordinary shares. The inclusion of Bilibili’s Class Z ordinary shares in the programs was pursuant to the Announcement on Adjustment of the Stock List of the Shenzhen-Hong Kong Stock Connect issued by the Shenzhen Stock Exchange...

TicketSmarter continues to build its primary ticking network by partnering with Spartan Race and the Professional Fighters League

Written by Customer Service on March 10, 2023. Posted in Public Companies.

Kansas City, March 10, 2023 (GLOBE NEWSWIRE) — TicketSmarter, a subsidiary of Digital Ally, Inc. (NASDAQ: DGLY), continues its partnership with Spartan Race and the Professional Fighters League (PFL), in which TicketSmarter is the official ticketing partner. Spartan is the world’s premier obstacle course race series with more than 300 events and more than seven million participants. PFL is one of the fastest growing and most innovative sports leagues, currently the second largest MMA company, globally. “We are excited to partner with these innovative companies to give fans and participants a fast and easy way to access these events,” TicketSmarter CEO Jeff Goodman said. “Each entity holds one-of-a-kind events and the growth of their devoted fanbases really speaks for themselves.” As the primary ticketing partner, TicketSmarter...

Sol-Gel Reports Full-Year 2022 Financial Results and Corporate Developments

Written by Customer Service on March 10, 2023. Posted in Earnings Releases And Operating Results.

Recent acquisition of Phase 3-ready SGT-610 (patidegib), an Orphan Drug candidate, broadens Sol-Gel’s pipeline with the potential to be the first therapy for preventing new basal cell carcinomas in Gorlin syndrome A Phase 3 study of SGT-610 is expected to initiate in the second half of 2023, with results expected by the end of 2025 The base of recurrent TWYNEO®prescribers was 82% in Q4 2022, while the EPSOLAY® recurrent prescriber base has grown to 64% during the same period Following recent financing, Sol-Gel’s cash runway expected to extend into the second half of 2025NESS ZIONA, Israel, March 10, 2023 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company with two innovative dermatology products that were launched in the U.S. and an innovative pipeline, today announced financial results for the...

Hersha Hospitality Trust Announces Quarterly Dividend

Written by Customer Service on March 10, 2023. Posted in Dividend Reports And Estimates.

PHILADELPHIA, March 10, 2023 (GLOBE NEWSWIRE) — Hersha Hospitality Trust (NYSE: HT) (“Hersha” or the “Company”), owner of luxury and lifestyle hotels in coastal gateway and resort markets, today announced its Board of Trustees has approved a cash dividend of $0.05 per common share and per limited partnership unit for the first quarter ending March 31, 2023. These common share dividends and limited partnership unit distributions are payable April 17, 2023, to holders of record as of March 31, 2023. The Board of Trustees also declared a cash dividend of $0.4297 per Series C Preferred Share, $0.40625 per Series D Preferred Share, and $0.40625 per Series E Preferred Share for the first quarter ending March 31, 2023. The preferred share dividends are payable April 17, 2023 to holders of record as of April 1, 2023. Hersha Hospitality...

Form 8.3 – [EMIS Group plc – 09 03 2023] – (CGWL)

Written by Customer Service on March 10, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree EMIS GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Form 8.3 – [Devro plc – 09 03 2023] – (CGWL)

Written by Customer Service on March 10, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree DEVRO PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals